Karin Herrera
Chief Tech/Sci/R&D Officer at COMPASS THERAPEUTICS, INC.
Profile
Karin Herrera is currently the Vice President & Head-Clinical Operations at Compass Therapeutics, Inc. She previously worked as the Vice President-Clinical Operations at Kadmon Corp.
LLC.
Ms. Herrera completed her undergraduate degree at Assumption College.
Karin Herrera active positions
Companies | Position | Start |
---|---|---|
COMPASS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2022 |
Former positions of Karin Herrera
Companies | Position | End |
---|---|---|
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Karin Herrera
Assumption College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
COMPASS THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Karin Herrera